162 related articles for article (PubMed ID: 27050379)
1. Genetic variants of CHRNA5-A3 and CHRNB3-A6 predict survival of patients with advanced non-small cell lung cancer.
Wang Y; Peng X; Zhu L; Hu L; Song Y
Oncotarget; 2016 May; 7(18):26436-43. PubMed ID: 27050379
[TBL] [Abstract][Full Text] [Related]
2. Is susceptibility locus for lung cancer in the 15q25 nicotinic acetylcholine receptor gene cluster CHRNA5-A3-B4 associated with risk of gastric cancer?
Wu H; Wang Y; Wang S; Jiang M; Wang C; Fu W; Hu L
Med Oncol; 2013; 30(2):576. PubMed ID: 23576140
[TBL] [Abstract][Full Text] [Related]
3. Association of CHRNA5-A3-B4 variation with esophageal squamous cell carcinoma risk and smoking behaviors in a Chinese population.
Wang Y; Wu H; Liu Q; Wang C; Fu L; Wang H; Zhu W; Fu W; Lv Y; Wang S; Hu L
PLoS One; 2013; 8(7):e67664. PubMed ID: 23844051
[TBL] [Abstract][Full Text] [Related]
4. Chronic Obstructive Pulmonary Disease Risk and Smoking Cessation Changes Induced by
Zhao L; Zou LY; Cheng BF; Yu XJ; Zou JH; Han W
Balkan J Med Genet; 2019 Dec; 22(2):51-58. PubMed ID: 31942417
[TBL] [Abstract][Full Text] [Related]
5. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
6. Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.
Zhang K; Tang S; Cao S; Hu L; Pan Y; Ma H; Guo X; Wu S; Shen H; Hu Z
Cancer Epidemiol; 2014 Aug; 38(4):414-8. PubMed ID: 24797335
[TBL] [Abstract][Full Text] [Related]
7. Association of the CHRNA3 locus with lung cancer risk and prognosis in Chinese Han population.
Niu X; Chen Z; Shen S; Liu Y; Zhou D; Zhang J; Li Z; Yu Y; Liao M; Lu S; He L
J Thorac Oncol; 2010 May; 5(5):658-66. PubMed ID: 20234319
[TBL] [Abstract][Full Text] [Related]
8. CHRNA5 gene D398N polymorphism in Japanese lung adenocarcinoma.
Sasaki H; Hikosaka Y; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
J Surg Res; 2010 Jul; 162(1):75-8. PubMed ID: 19577767
[TBL] [Abstract][Full Text] [Related]
9. Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients.
Carcereny E; Ramirez JL; Sanchez-Ronco M; Isla D; Cobo M; Moran T; de Aguirre I; Okamoto T; Wei J; Provencio M; Lopez-Vivanco G; Camps C; Domine M; Alberola V; Sanchez JM; Massuti B; Mendez P; Taron M; Rosell R
Lung Cancer; 2010 Jun; 68(3):491-7. PubMed ID: 19733931
[TBL] [Abstract][Full Text] [Related]
10. The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients.
Wang S; Wang J; Bai Y; Wang Q; Liu L; Zhang K; Hong X; Deng Q; Zhang X; He M; Wu T; Xu P; Guo H
Cancer Med; 2016 Sep; 5(9):2332-42. PubMed ID: 27465648
[TBL] [Abstract][Full Text] [Related]
11. Functional effect of polymorphisms in 15q25 locus on CHRNA5 mRNA, bulky DNA adducts and TP53 mutations.
Tekpli X; Landvik NE; Skaug V; Gulsvik A; Haugen A; Zienolddiny S
Int J Cancer; 2013 Apr; 132(8):1811-20. PubMed ID: 23011884
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants in
He Y; Wang G; Wang Q; Zhao Z; Gan L; Yang S; Wang Y; Guo S; An J; Zhang J; Zhang Z; Zhou F
Future Oncol; 2021 Mar; 17(7):795-805. PubMed ID: 33541123
[No Abstract] [Full Text] [Related]
13. Chromosome 15q25 (CHRNA3-CHRNB4) Variation Indirectly Impacts Lung Cancer Risk in Chinese Males.
Zhang Y; Jiang M; Li Q; Liang W; He Q; Chen W; He J
PLoS One; 2016; 11(3):e0149946. PubMed ID: 26942719
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants of NBS1 predict clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer in Chinese.
Xu JL; Hu LM; Huang MD; Zhao W; Yin YM; Hu ZB; Ma HX; Shen HB; Shu YQ
Asian Pac J Cancer Prev; 2012; 13(3):851-6. PubMed ID: 22631660
[TBL] [Abstract][Full Text] [Related]
15. A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).
Azad AK; Qiu X; Boyd K; Kuang Q; Emami M; Perera N; Palepu P; Patel D; Chen Z; Cheng D; Feld R; Leighl NB; Shepherd FA; Tsao MS; Xu W; Liu G; Cuffe S
Lung Cancer; 2014 Jun; 84(3):289-94. PubMed ID: 24679952
[TBL] [Abstract][Full Text] [Related]
16. The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen.
Geng N; Su J; Liu Z; Ding C; Xie S; Hu W
Technol Cancer Res Treat; 2021; 20():15330338211019433. PubMed ID: 34060368
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of cyclooxygenase-2 gene polymorphisms in advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.
Liu L; Zhou F; Ren S; Chen X; Li X; Li W; Zhou C
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e339-46. PubMed ID: 25131817
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis.
Song B; Liu Y; Liu J; Song X; Wang Z; Wang M; Zhu Y; Han J
Respiration; 2011; 82(5):439-44. PubMed ID: 21832820
[TBL] [Abstract][Full Text] [Related]
19. Association of the transforming growth factor ß1 promoter polymorphism, C-509T, with smoking status and survival in advanced non-small cell lung cancer.
Togashi Y; Masago K; Fujita S; Kim YH; Sakamori Y; Hatachi Y; Fukuhara A; Nagai H; Mio T; Mishima M
Oncol Rep; 2011 Feb; 25(2):377-82. PubMed ID: 21165571
[TBL] [Abstract][Full Text] [Related]
20. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.
Wassenaar CA; Dong Q; Wei Q; Amos CI; Spitz MR; Tyndale RF
J Natl Cancer Inst; 2011 Sep; 103(17):1342-6. PubMed ID: 21747048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
